Medicinal Products

Dáil Éireann Debate, Tuesday - 24 September 2024

• Debates
• Find a debate
  • Dáil debates
  • Seanad debates
  • Committee debates
• Find a vote
  • Dáil votes
  • Seanad votes
  • Committee votes
• Parliamentary questions
  • Written questions
  • Oral questions
• Search tips
• Utterances having an adverse effect

Tuesday, 24 September 2024

Questions (539)

David Cullinane

Question:

539. Deputy David Cullinane asked the Minister for Health if semaglutide is licensed and approved for use for insulin resistance, weight management or any other purpose in the State; if it is approved or under consideration for reimbursement in any context other than type 2 diabetes; and if he will make a statement on the matter. [37878/24]

Written answers

Minister for Health

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.

• Previous Answer
• Next Answer